Today's announcement regarding the patent filing for skin ulcers brings the company's IP portfolio to (either owned or licensed to Oculus) to 33 issued patents (seven in the U.S. and two in the E.U.) and 113 pending applications for chemical compositions, apparatuses, methods of manufacturing and therapeutic uses. Most of these were "fast track" based on the chemical composition of OCLS products - the next step is to do clinical trials for in vivo (in the body) apps - which is more complex and expensive, which is why the Rutigen spin off suddenly becomes important. This strong IP protection is one of the overlooked value propositions that should be included in the valuation of OCLS.
Don't bother answering ingerstupid69... he used to work for Oculus in the past and got fired a few years ago and ever since he is bashing the company in every way he can. Just an old man trying to shake his bad energy...
Just in case there is anyone who hasn't been around here for long, understand that ikabro has a vivid imagination and a real knack for making prophecies and predictions which never come true. He also posts to this board on under more than a dozen aliases, often replying to himself. A couple days ago he made 16 posts under five aliases in a few minutes.
For the record, I have never been employed by OCLS or anyone associated with OCLS. I have never been fired and I have been employed by my current employer for over 30 years.
Strong IP protection, LOL. Nothing they have can stop a competitor from mixing up microcyn using bleach, water, salt and acid and using it for any purpose they want. They have no patent covering microcyn compositions. None. Not one. If you want to deny this, just cite a patent number. I have been asking for that for over three years and no one has been able to cite one because none exists. None, count 'em, none.
Yes, but you can say the same thing about toothpaste. Or soap. And yet, companies make billions selling these formulations. OCLS has hit on a Procter and Gamble or Johnson and Johnson approach to surgical cleansing. Nice strategy. When is the last time you heard someone comment on the chemistry in toothpaste or soap? The same applies to OCLS. It's sheer marketing and strategy. If you do it well, you make money, and that's what they're doing.